ANIXA BIOSCIENCES, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-04-30 was $4.00K, a 0.00% change year-over-year.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-10-31 was $3.00K, a 0.00% change year-over-year.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $7.00K, a 30.00% decline from fiscal 2024.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $10.00K, a 23.08% decline from fiscal 2023.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $13.00K, a 0.00% change from fiscal 2022.
- ANIXA BIOSCIENCES, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $13.00K, a 116.67% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | |
| 2026-04-30 | $4.00K 10-Q · filed 2026-06-10 | |
| 2025-10-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $7.00K 10-K · filed 2026-01-12 |
| 2025-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | |
| 2025-04-30 | $4.00K 10-Q · filed 2026-06-10 | |
| 2024-10-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $10.00K 10-K · filed 2026-01-12 |
| 2024-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10 | |
| 2024-04-30 | $7.00K 10-Q · filed 2025-05-28 | |
| 2023-10-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $13.00K 10-K · filed 2025-01-10 |
| 2023-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-09-06 | |
| 2023-04-30 | $6.00K 10-Q · filed 2024-06-04 | |
| 2022-10-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16 | $13.00K 10-K · filed 2024-01-16 |
| 2022-07-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-09-06 | |
| 2022-04-30 | $7.00K 10-Q · filed 2023-06-14 | |
| 2021-10-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $6.00K 10-K · filed 2023-01-04 |
| 2021-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-09 | |
| 2021-04-30 | $3.00K 10-Q · filed 2022-06-10 | |
| 2020-10-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04 | $18.45K 10-K · filed 2022-01-04 |
| 2020-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-01 | |
| 2020-04-30 | $15.45K 10-Q · filed 2021-06-10 | |
| 2019-10-31 | $20.53K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $39.09K 10-K · filed 2021-01-07 |
| 2019-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-09-08 | |
| 2019-04-30 | $18.56K 10-Q · filed 2020-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |